XML 73 R56.htm IDEA: XBRL DOCUMENT v3.19.2
SHARE-BASED COMPENSATION PLANS (Tables)
 12 Months Ended
Jun. 30, 2019
Share-based Payment Arrangement [Abstract]  
Share-based compensation expense
Total share-based compensation is shown in the table below:
 
2019
 
2018
 
2017
Equity plan expense
$
16.9

 
$
31.6

 
$
20.0

Liability plan (income) expense
(2.1
)
 
(1.0
)
 
4.6

Fringe expense
0.4

 
2.8

 
4.4

Total share-based compensation expense
$
15.2

 
$
33.4

 
$
29.0
Fair value valuation assumptions
During fiscal 2019, 2018 and 2017, the share-based compensation expense recognized on nonqualified stock options is based upon the fair value on the grant date estimated using the Black-Scholes valuation model with the following weighted-average assumptions:
 
2019
 
2018
 
2017
Expected life
6.50 years
 
7.50 years
 
7.50 years
Risk-free interest rate
2.56%
 
2.19%
 
1.60%
Expected volatility
40.73%
 
36.03%
 
36.74%
Expected dividend yield
4.64%
 
2.98%
 
1.62%

As of June 30, 2019, the fair value of the Company’s outstanding Series A and Series A-1 Preferred Stock that are liability accounted were estimated with the following weighted-average assumptions.
 
2019
 
2018
 
2017
Expected life, in years
4.97 years
 
4.52 years
 
5.86 years
Expected volatility
42.53%
 
35.00%
 
30.00%
Risk-free rate of return
2.45%
 
2.70%
 
1.99%
Dividend yield on Class A Common Stock
6.19%
 
3.55%
 
2.67%
Yield on cash
N/A
 
N/A
 
4.70%
Outstanding nonqualified stock option activity
The Company’s outstanding nonqualified stock options as of June 30, 2019 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
Term (in years)
Outstanding at July 1, 2018
13.4

 
$
16.75

 
 
 
 
Granted
19.4

 
10.89

 
 
 
 
Exercised
(0.6
)
 
9.14

 
 
 
 
Forfeited
(4.3
)
 
16.42

 
 
 
 
Outstanding at June 30, 2019
27.9

 
$
12.89

 
 
 
 
Vested and expected to vest at June 30, 2019
18.9

 
$
12.85

 
$
10.4

 
8.67
Exercisable at June 30, 2019
1.1

 
$
10.04

 
$
3.50

 
1.63
Schedule of Stock Summary
A summary of the aggregated weighted-average grant date fair value of stock options granted and total intrinsic value of stock options exercised for fiscal 2019, 2018 and 2017 is presented below:
 
2019
 
2018
 
2017
Weighted-average grant date fair value of stock options
$
2.87

 
$
4.87

 
$
6.34

Intrinsic value of options exercised
11.5

 
32.2

 
26.3
Schedule of non-vested nonqualified share activity
The Company’s non-vested shares of Series A and Series A-1 Preferred Stock as of June 30, 2019 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Grant Date
Fair Value
Non-vested at July 1, 2018
4.0

 
$
4.99

Granted
7.9

 
1.24

Forfeited
(3.5
)
 
5.16

Non-vested at June 30, 2019
8.4

 
$
1.39


The Company’s non-vested nonqualified stock options as of June 30, 2019 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Grant Date
Fair Value
Non-vested at July 1, 2018
11.7

 
$
5.60

Granted
19.4

 
2.87

Forfeited
(4.3
)
 
5.03

Non-vested at June 30, 2019
26.8

 
$
3.72
Scheduled of outstanding Series A Preferred shares
The Company’s outstanding Series A and Series A-1 Preferred Shares as of June 30, 2019 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Exercise Price
 
Aggregate Intrinsic Value
 
Weighted Average Remaining Contractual Term (in years)
Outstanding at July 1, 2018
5.0

 
$
23.62

 
 
 
 
Granted
7.9

 
9.46

 
 
 
 
Forfeited
(3.5
)
 
$
24.28

 
 
 
 
Outstanding at June 30, 2019
9.4

 
$
11.47

 
 
 
 
Vested and expected to vest at June 30, 2019
8.9

 
$
10.91

 
$
22.20

 
6.25
Outstanding RSU activity
The Company’s outstanding RSUs as of June 30, 2019 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Aggregate
Intrinsic
Value
 
Weighted
Average
Remaining
Contractual
Term
Outstanding at July 1, 2018
7.5

 
 
 
 
Granted
7.0

 
 
 
 
Settled
(0.6
)
 
 
 
 
Cancelled
(3.4
)
 
 
 
 
Outstanding at June 30, 2019
10.5

 
 
 
 
Vested and expected to vest at June 30, 2019
8.6

 
$
114.4

 
2.16
Outstanding and non-vested RSU activity
The Company’s outstanding and non-vested RSUs as of June 30, 2019 and activity during the fiscal year then ended are presented below:
 
Shares
(in millions)
 
Weighted
Average
Grant Date
Fair Value
Outstanding and nonvested at July 1, 2018
7.2

 
$
19.57

Granted
7.0

 
11.38

Vested
(0.6
)
 
17.49

Cancelled
(3.4
)
 
17.46

Outstanding and nonvested at June 30, 2019
10.2

 
$
14.79